Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-26 @ 4:12 AM
Study NCT ID:
NCT00007527
Status:
COMPLETED
Last Update Posted:
2009-01-21
First Post:
2000-12-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
Sponsor:
US Department of Veterans Affairs
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-08
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2002-01
Completion Date Type:
None
First Submit Date:
2000-12-29
First Submit QC Date:
None
Study First Post Date:
2001-01-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-01-20
Last Update Post Date:
2009-01-21
Last Update Post Date Type:
ESTIMATED